Sorrento Therapeutics, Inc. - FORM 10-K - EX-23.1 - CONSENT OF MAYER HOFFMAN MCCANN P.C. - March 18, 2011

Attached files

file filename
10-K - FORM 10-K - Sorrento Therapeutics, Inc.d10k.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - Sorrento Therapeutics, Inc.dex311.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER - Sorrento Therapeutics, Inc.dex321.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - Sorrento Therapeutics, Inc.dex312.htm
EX-10.12 - THIRD AMENDMENT TO OFFICE LEASE - Sorrento Therapeutics, Inc.dex1012.htm
EX-10.13 - FOURTH AMENDMENT TO OFFICE LEASE - Sorrento Therapeutics, Inc.dex1013.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement No. 333-163670 on Form S-8 of our report dated March 18, 2011, relating to the financial statements of Sorrento Therapeutics, Inc. for the year ended December 31, 2010, appearing in this Annual Report on Form 10-K of Sorrento Therapeutics, Inc.

/s/ Mayer Hoffman McCann P.C.

San Diego, California

March 18, 2011

Sorrento Therapeutics, Inc. Reports